PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
August 01, 2024 16:03 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
August 01, 2024 16:02 ET
|
Alvotech
REYKJAVIK, Iceland, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
Monolithic Power Systems to Report Second Quarter Results on August 1, 2024
August 01, 2024 16:01 ET
|
Monolithic Power Systems, Inc.
KIRKLAND, Wash., Aug. 01, 2024 (GLOBE NEWSWIRE) -- MPS will report its results after the market closes on August 1, 2024 and host a question-and-answer webinar at 2:00 p.m. PT / 5:00 p.m. ET. The...
WillScot Reports Second Quarter 2024 Results
August 01, 2024 16:01 ET
|
WillScot
PHOENIX, Aug. 01, 2024 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced...
Monolithic Power Systems Announces Results for the Second Quarter Ended June 30, 2024
August 01, 2024 16:01 ET
|
Monolithic Power Systems, Inc.
KIRKLAND, Wash., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power...
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
August 01, 2024 16:01 ET
|
Ardelyx, Inc.
IBSRELA generates $35.4 million in net product sales revenue XPHOZAH generates $37.1 million in net product sales revenue Company ends Q2 with approximately $186 million in cash and investments ...
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
August 01, 2024 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first half of the...
Alvotech mun birta uppgjör fyrri árshelmings 2024 fimmtudaginn 15. ágúst nk. og streyma uppgjörsfundi föstudaginn 16. ágúst nk. kl. 12:00 að íslenskum tíma
August 01, 2024 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2024 eftir lokun markaða í Bandaríkjunum, fimmtudaginn 15. ágúst nk. Þá mun Alvotech halda kynningarfund fyrir...
Asure Announces Second Quarter 2024 Results
August 01, 2024 16:01 ET
|
Asure Operations
Reports Second Quarter Revenues of $28 Million Recurring Revenues Grew 18% Versus Prior Year Second Quarter AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”,...
Xenon to Report Q2 2024 Financial Results on August 8, 2024
August 01, 2024 16:01 ET
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and...